Reviewed clinical summary · Source-linked · Educational use only

Can Exercise and Broccoli Improve Heart and Metabolic Health in Type 2 Diabetes?

Clinical Bottom Line

An RCT finds combining exercise with broccoli sprout supplementation improves apolipoproteins in type 2 diabetes, mainly driven by exercise. PICO summary and expert commentary.

Summary: In men with type 2 diabetes, combining 12 weeks of structured exercise with broccoli sprout supplementation improved apolipoproteins and glycaemic markers more than either alone, with the benefit driven mainly by exercise and no adverse effects reported.

PICO Summary

ElementDetail
Population44 men with type 2 diabetes, randomised to four groups.
Intervention12 weeks of aerobic plus resistance training (3/week, 60–70% 1RM/VO₂peak) plus 10 g/day broccoli sprout supplement after meals.
ComparisonNo-intervention control; training only; supplement only.
OutcomeCombined arm showed the largest gains: ApoA-I +44.9 mg/dL, ApoB-100 -48.3 mg/dL, ApoJ -44.1 mg/dL, with significant falls in glucose, insulin and HOMA-IR. Effect-size analysis indicated benefit was primarily exercise-driven.
RCT Nutrients · 2025

Exercise + broccoli sprouts in type 2 diabetes

RCT · type 2 diabetes · 12 weeks

Trial design
44 men with type 2 diabetes Enrolled & assessed RANDOMISED 1:1:1:1 Training + supplement Exercise + broccoli n = 11 Control No intervention n = 11 Change in ApoB-100 at 12 weeks
Change from baseline — both arms
ApoB-100 (mg/dL) Baseline Week 12 -48.3 mg/dL Training + supplement Control
ApoB-100
-48.3 mg/dL
Combined arm
ApoA-I
+44.9 mg/dL
Combined arm
ApoJ
-44.1 mg/dL
Combined arm
HOMA-IR
Reduced
Exercise-driven
⬡ Bottom Line

Combining 12 weeks of exercise with broccoli sprouts improved apolipoproteins and glycaemia more than either alone, but the gain was largely exercise-driven. Surrogate markers only, 44 men, 12 weeks.

Expert Commentary

The honest story of this trial is told in its own effect sizes, and I appreciate that the authors say it plainly: the benefit was primarily driven by exercise, with the broccoli sprouts a complementary and less consistent add-on. That framing matches my clinical instinct, because structured training is already a cornerstone of diabetes care with reliable effects on insulin sensitivity and lipids, whereas sulforaphane remains a preliminary glucose-lowering signal at best. The four-arm design is a strength, letting me see the supplement’s modest standalone contribution rather than a blurred combination. The apolipoprotein detail is a nice touch too, since ApoB tells me more about atherogenic risk than a standard panel. My caution is the familiar set: 44 men only, twelve weeks, surrogate biomarkers, and a supplement whose sulforaphane content is hard to standardise. Can I use this with my patients? Yes, but with the emphasis exactly where the data put it, prioritise the exercise, treat broccoli sprouts as a harmless extra for the keen, and never let either displace glucose-lowering medication. I would want hard outcomes and a mixed-sex population before saying more.

References

Delfan M, Gharedaghi M, Zeynali F, et al. Combined effects of exercise and broccoli supplementation on metabolic and lipoprotein biomarkers in adults with type 2 diabetes: a randomized controlled trial. Nutrients. 2025;17(17):2735. doi:10.3390/nu17172735

Educational use: Hormone Insight is intended for healthcare professionals and learners. Interpret each summary alongside the primary source, local guidance, and patient-specific clinical judgement.

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

© 2024-2026 Hormone Insight. All rights reserved.